Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection - PubMed (original) (raw)

. 1999 Nov;104(10):1431-9.

doi: 10.1172/JCI7162.

M Dupuis, J C Deschemin, C Goujard, C Deveau, L Meyer, N Ngo, C Rouzioux, J G Guillet, J F Delfraissy, M Sinet, A Venet

Affiliations

Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection

M Dalod et al. J Clin Invest. 1999 Nov.

Abstract

HIV-specific CD8(+) T cells play a major role in the control of virus during HIV primary infection (PI) but do not completely prevent viral replication. We used IFN-gamma enzyme-linked immunospot assay and intracellular staining to characterize the ex vivo CD8(+) T-cell responses to a large variety of HIV epitopic peptides in 24 subjects with early HIV PI. We observed HIV-specific responses in 71% of subjects. Gag and Nef peptides were more frequently recognized than Env and Pol peptides. The number of peptides recognized was low (median 2, range 0-6). In contrast, a much broader response was observed in 30 asymptomatic subjects with chronic infection: all were responders with a median of 5 peptides recognized (range 1-13). The frequency of HIV-specific CD8(+) T cells among PBMC for a given peptide was of the same order of magnitude in both groups. The proportion of HIV-specific CD8(+)CD28(-) terminally differentiated T cells was much lower in PI than at the chronic stage of infection. The weakness of the immune response during HIV PI could partially account for the failure to control HIV. These findings have potential importance for defining immunotherapeutic strategies and establishing the goals for effective vaccination.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Comparison of anti-HIV CD8+ T-cell responses of HIV-infected subjects in PI (a) and during chronic infection (b). The Y axis represents the numbers of tested peptides; black bars show numbers of recognized peptides; and white bars show numbers of peptides not recognized. Each bar on the X axis represents the data obtained for 1 individual.

Figure 2

Figure 2

Comparison of the frequencies of anti-HIV CD8+ T-cell responses for different HLA restriction elements. The mean percentages (and standard deviation) of viral epitopic peptides recognized are shown for each HLA restriction element for HIV-infected individuals during PI (open bars) or chronic infection (filled bars).

Figure 3

Figure 3

Level of CD8+ T-cell activation in peripheral blood. Bars represent percentages (±SD) of CD8+HLA-DR+, CD8+CD38+, CD8+CD45RO+, and CD8+CD28+ in PBMC of HIV-infected subjects during PI (gray bars) and chronic infection (black bars) as compared with control HIV-seronegative individuals (white bars).

Figure 4

Figure 4

Comparison of the proportion of CD8+CD28+ T cells specific for HIV or other viral peptides among CD8+ T cells. (a) Representative experiments from 3 HLA-B8–expressing individuals where PBMC were incubated in medium alone or stimulated with peptides EBNA-3 325-333 derived from EBV and Gag 259-267 from HIV-1. IFN-γ intracellular production (x axis) and CD28 expression (y axis) were analyzed on gated CD8+ T lymphocytes. 200,000 events were acquired for subject KJA and 400,000 for the other individuals. Absolute numbers of events are indicated in the right quadrants of each dot-plot. (b) Boxes representing the fraction of CD8+ CD28+ T cells (25th–75th percentile) specific for HIV peptides (gray boxes) or for influenza or EBV peptides (white boxes) in subjects with PI (n = 14) or chronic HIV infection (n = 14), and seronegative controls (n = 4).

Similar articles

Cited by

References

    1. Pantaleo G, Graziosi C, Fauci AS. Virologic and immunologic events in primary HIV infection. Springer Semin Immunopathol. 1997;18:257–266. - PubMed
    1. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339:33–39. - PubMed
    1. Koup RA, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J Virol. 1994;68:4650–4655. - PMC - PubMed
    1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MBA. Virus-specific CD8+ cytotoxic T lymphocytes activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol. 1994;68:6103–6110. - PMC - PubMed
    1. Schmitz JE, et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science. 1999;283:857–860. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources